164 related articles for article (PubMed ID: 24259282)
1. Safety of botulinum toxin for dysphagia in oculopharyngeal muscular dystrophy.
Youssof S; Schrader RM; Romero-Clark C; Roy G; Spafford M
Muscle Nerve; 2014 Apr; 49(4):601-3. PubMed ID: 24259282
[TBL] [Abstract][Full Text] [Related]
2. Safety of botulinum toxin for dysphagia in oculopharyngeal muscular dystrophy.
Restivo DA; Marchese-Ragona R
Muscle Nerve; 2014 Nov; 50(5):869-70. PubMed ID: 25155080
[No Abstract] [Full Text] [Related]
3. Botulinum toxin treatment improves dysphagia in patients with oculopharyngeal muscular dystrophy and sporadic inclusion body myositis.
Witting N; Daugaard D; Prytz S; Biernat H; Diederichsen LP; Vissing J
J Neurol; 2022 Aug; 269(8):4154-4160. PubMed ID: 35244767
[TBL] [Abstract][Full Text] [Related]
4. Reply: To PMID 24259282.
Youssof S; Spafford M
Muscle Nerve; 2014 Nov; 50(5):870-1. PubMed ID: 25155195
[No Abstract] [Full Text] [Related]
5. Oropharyngeal dysphagia profiles in individuals with oculopharyngeal muscular dystrophy.
Tabor LC; Plowman EK; Romero-Clark C; Youssof S
Neurogastroenterol Motil; 2018 Apr; 30(4):e13251. PubMed ID: 29144056
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin in the treatment of cricopharyngeal dysphagia.
Haapaniemi JJ; Laurikainen EA; Pulkkinen J; Marttila RJ
Dysphagia; 2001; 16(3):171-5. PubMed ID: 11453562
[TBL] [Abstract][Full Text] [Related]
7. Botulinum Toxin A Injection Using Esophageal Balloon Radiography Combined with CT Guidance for the Treatment of Cricopharyngeal Dysphagia.
Huai J; Hou Y; Guan J; Zhang Y; Wang Y; Zhang X; Zhang Y; Yue S
Dysphagia; 2020 Aug; 35(4):630-635. PubMed ID: 31620859
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin injection for the treatment of upper esophageal sphincter dysfunction.
Kelly EA; Koszewski IJ; Jaradeh SS; Merati AL; Blumin JH; Bock JM
Ann Otol Rhinol Laryngol; 2013 Feb; 122(2):100-8. PubMed ID: 23534124
[TBL] [Abstract][Full Text] [Related]
9. Successful botulinum toxin treatment of dysphagia in oculopharyngeal muscular dystrophy.
Restivo DA; Marchese Ragona R; Staffieri A; de Grandis D
Gastroenterology; 2000 Nov; 119(5):1416. PubMed ID: 11185464
[No Abstract] [Full Text] [Related]
10. The requirement for a disease-specific patient-reported outcome measure of dysphagia in oculopharyngeal muscular dystrophy.
Côté C; Gagnon C; Youssof S; sKurtz N; Brais B
Muscle Nerve; 2019 Apr; 59(4):445-450. PubMed ID: 30575974
[TBL] [Abstract][Full Text] [Related]
11. Ultrasonography-guided botulinum toxin injection to the cricopharyngeus muscle: a case report and technical notes.
Wang YC; Wu CH; Shyu SG; Hsiao MY; Wang TG
Med Ultrason; 2020 Sep; 22(3):345-355. PubMed ID: 32190858
[TBL] [Abstract][Full Text] [Related]
12. Cricopharyngeal dilatation for the long-term treatment of dysphagia in oculopharyngeal muscular dystrophy.
Manjaly JG; Vaughan-Shaw PG; Dale OT; Tyler S; Corlett JC; Frost RA
Dysphagia; 2012 Jun; 27(2):216-20. PubMed ID: 21805106
[TBL] [Abstract][Full Text] [Related]
13. [Botulinum toxin injection into the cricopharyngeal muscle for dysphagia: report of 2 successful cases].
Yokoyama T; Asai M; Kumada M; Usui S; Kobayasi T
Nihon Jibiinkoka Gakkai Kaiho; 2003 Jul; 106(7):754-7. PubMed ID: 12931643
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic botulinum toxin injection for treatment of pharyngeal dysphagia in patients with cricopharyngeal dysfunction.
Jeong SH; Kim YJ; Kim YJ; Park KD; Kim EJ; Chung JW; Kwon KA; Kim KO; Park DK; Kim JH; Cho JH
Scand J Gastroenterol; 2018; 53(10-11):1201-1205. PubMed ID: 30353754
[TBL] [Abstract][Full Text] [Related]
15. A study of impairments in oculopharyngeal muscular dystrophy.
Brisson JD; Gagnon C; Brais B; Côté I; Mathieu J
Muscle Nerve; 2020 Aug; 62(2):201-207. PubMed ID: 32270505
[TBL] [Abstract][Full Text] [Related]
16. Utility of surgical myotomy in the dysphagia due to oculopharyngeal dystrophy.
Acosta Mérida Mª; Marchena Gómez J; Afonso Déniz JM
Rev Esp Enferm Dig; 2016 Dec; 108(12):843-844. PubMed ID: 27809552
[TBL] [Abstract][Full Text] [Related]
17. A Preliminary Videofluoroscopic Investigation of Swallowing Physiology and Function in Individuals with Oculopharyngeal Muscular Dystrophy (OPMD).
Waito AA; Steele CM; Peladeau-Pigeon M; Genge A; Argov Z
Dysphagia; 2018 Dec; 33(6):789-802. PubMed ID: 29725764
[TBL] [Abstract][Full Text] [Related]
18. Hip flexion weakness is associated with impaired mobility in oculopharyngeal muscular dystrophy: a retrospective study with implications for trial design.
Youssof S; Schrader R; Bear D; Morrison L
Neuromuscul Disord; 2015 Mar; 25(3):238-46. PubMed ID: 25500011
[TBL] [Abstract][Full Text] [Related]
19. Oculopharyngeal Muscular Dystrophy, an Often Misdiagnosed Neuromuscular Disorder: A Southern California Experience.
Goyal NA; Mozaffar T; Chui LA
J Clin Neuromuscul Dis; 2019 Dec; 21(2):61-68. PubMed ID: 31743248
[TBL] [Abstract][Full Text] [Related]
20. The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia.
Holzer SE; Ludlow CL
Laryngoscope; 1996 Jan; 106(1 Pt 1):86-92. PubMed ID: 8544635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
